Bio Rad Laboratories Inc
Change company Symbol lookup
Select an option...
BIO Bio Rad Laboratories Inc
LIN Linde PLC
ENLV Enlivex Therapeutics Ltd
WSTG Wayside Technology Group Inc
ATRO Astronics Corp
BHR Braemar Hotels & Resorts Inc
NBSTU Newbury Street Acquisition Corp
SKX Skechers USA Inc
IGICW International General Insurance Holdings Equity Warrants 17th March 2025 *W EXP 03/17/2025
NHIC Newhold Investment II Corp
Go

Health Care : Life Sciences Tools & Services | Mid Cap Growth
Company profile

Bio-Rad Laboratories, Inc. manufactures and supplies the life science research, healthcare, analytical chemistry and other markets with a range of products and systems used to separate chemical and biological materials and to identify, analyze and purify their components. Its segments include Life Science and Clinical Diagnostics. Its Life Science segment markets and develops, manufactures and markets approximately 9,000 reagents, apparatus and laboratory instruments that serve a global customer base. Its products are used in research techniques, biopharmaceutical production processes and food testing regimes. Its Clinical Diagnostics segment designs, manufactures, sells and supports test systems, informatics systems, test kits and specialized quality controls that serve clinical laboratories in the global diagnostics market. It supplies approximately 3,000 different products that cover over 300 clinical diagnostic tests to the in vitro diagnostics (IVD) test market.

Closing Price
$495.16
Day's Change
-12.53 (-2.47%)
Bid
--
Ask
--
B/A Size
--
Day's High
513.45
Day's Low
495.05
Volume
(Average)
Volume:
173,156

10-day average volume:
176,998
173,156

BIO's position in the Life Sciences Tools & Services industry

Industry PeersBIOILMNPKITECHTXG

Summary

Company ProfileBio-Rad Laboratories, Inc. manufactures and supplies the life science research, healthcare, analytical chemistry and other markets with a range of products and systems used to separate chemical and...
Illumina, Inc. is a provider of sequencing- and array-based solutions for genetic and genomic analysis. The Company operates through two segments: Core Illumina and GRAIL. Core Illumina products and...
Go to ILMN summary
PerkinElmer, Inc. is a provider of products, services and solutions for the diagnostics, life sciences and applied markets. The Company operates through two segments: Discovery & Analytical Solutions...
Go to PKI summary
Bio-Techne Corporation is a developer, manufacturer, and seller of life science reagents, instruments and services for the research, diagnostics, and bioprocessing markets. The Company operates...
Go to TECH summary
10x Genomics, Inc. is a life science technology company. The Company's integrated solutions include instruments, consumables, and software for analyzing biological systems. Its products include...
Go to TXG summary
52-Week Change

VS. INDUSTRY
-23.08%
-61.07%
-8.73%
-22.24%
-76.72%
Market Cap

VS. INDUSTRY
$15.0B
$30.4B
$18.3B
$13.9B
$5.5B
Beta

VS. INDUSTRY
0.9
1.1
1.1
1.2
--
Dividend Yield

VS. INDUSTRY
--
--
0.19%
0.36%
--
P/E (TTM, GAAP)

VS. INDUSTRY
--
42.17x
23.39x
64.46x
--
Data as of

Fundamentals

Total Revenue (TTM)

VS. INDUSTRY
$2.9B
$4.7B
$5.0B
$1.1B
$499.2M
Profit Margin

VS. INDUSTRY
-3.49%
15.03%
14.76%
20.05%
-17.85%
Earnings Growth
(5 year, GAAP)

VS. INDUSTRY
176.04%
10.06%
32.83%
4.37%
--
Revenue Growth (TTM)

VS. INDUSTRY
7.22%
34.06%
13.09%
26.96%
50.01%
Data as of
Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Copyright © 2022. All rights reserved.

Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.

Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.